Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement

Safety and effectiveness of gemcitabine for the treatment of classic Kaposi’s sarcoma without visceral involvement

Background: Classic Kaposi’s sarcoma (CKS) is a rare, multifocal, endothelial cell neoplasm that typically occurs in elderly people with previous infection by human herpes virus-8. Prospective trials are rare, and the choice of drugs relies on prospective trials performed on HIV-associated Kaposi’s...

Full description

Bibliographic Details
Main Authors: Giuseppe Badalamenti, Lorena Incorvaia, Laura Algeri, Annalisa Bonasera, Alessandra Dimino, Raimondo Scalia, Alessandra Cucinella, Giorgio Madonia, Federica Li Pomi, Antonio Galvano, Valerio Gristina, Francesca Toia, Adriana Cordova, Viviana Bazan, Antonio Russo
Format: Article
Language:English
Published: SAGE Publishing 2022-03-01
Series:Therapeutic Advances in Medical Oncology
Online Access:https://doi.org/10.1177/17588359221086829

Internet

https://doi.org/10.1177/17588359221086829

Similar Items